Quick Answer
Lexeo Therapeutics, Inc. reported Shares Outstanding of 73.00 million shares for fiscal year 2025.
Lexeo Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 73.00M | +120.7% |
| 2024 | 33.07M | +24.1% |
| 2023 | 26.65M | +1558.0% |
| 2022 | 1.61M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 54.93M | +66.2% | +1.7% |
| June 30, 2025 | 54.00M | +63.4% | +62.7% |
| March 31, 2025 | 33.19M | +0.8% | +0.4% |
| December 31, 2024 | 33.07M | +24.1% | +0.0% |
| September 30, 2024 | 33.06M | +1924.1% | +0.1% |
| June 30, 2024 | 33.04M | — | +0.3% |
| March 31, 2024 | 32.93M | — | +23.6% |
| December 31, 2023 | 26.65M | +1558.0% | +1531.5% |
- Lexeo Therapeutics, Inc. showed an increase of +120.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2022–2025 period, Lexeo Therapeutics, Inc.’s shares outstanding has grown by 4442.2% (from 1.61 million shares to 73.00 million shares).
- The most recent figure is from Lexeo Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: